Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

被引：1
|
作者：
Arora, Ritu [1 ]
Gary, Bernard D. [1 ]
McClellan, Steven [1 ]
Xi, Yaguang [1 ]
Piazza, Gary [1 ]
Reed, Eddie [1 ]
Owen, Laurie [1 ]
Dean-Colomb, Windy [1 ]
机构：
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5571
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A novel mechanism for therapeutic targeting of the glucocorticoid receptor in triple negative breast cancer
    Khan, Shagufta H.
    Carbe, Christian
    Ling, Jun
    Kumar, Raj
    CANCER RESEARCH, 2023, 83 (07)
  • [42] CDC20 is a novel therapeutic target in triple negative breast cancer
    Sharma, J.
    Raicu, I.
    Nguyen, J.
    Udden, N.
    Wang, Q.
    Alluri, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [43] Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer
    Rhodes, Lyndsay V.
    Tilghman, Syreeta L.
    Boue, Stephen M.
    Wang, Shuchun
    Khalili, Hafez
    Muir, Shannon E.
    Bratton, Melyssa R.
    Zhang, Qiang
    Wang, Guangdi
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    ONCOLOGY LETTERS, 2012, 3 (01) : 163 - 171
  • [44] Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
    Lee, Alice
    Djamgoz, Mustafa B. A.
    CANCER TREATMENT REVIEWS, 2018, 62 : 110 - 122
  • [45] Novel chalcone derivatives as potential therapeutic agents for triple negative breast cancer
    Kumar, Vineet
    Going, Catherine
    Tailor, Dhanir
    Pandrala, Mallesh
    Birk, Alisha
    Pitteri, Sharon
    Malhotra, Sanjay
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [46] ADAM-17: a novel therapeutic target for triple negative breast cancer
    McGowan, P. M.
    Mullooly, M.
    Caiazza, F.
    Sukor, S.
    Madden, S. F.
    Maguire, A. A.
    Pierce, A.
    McDermott, E. W.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 362 - 369
  • [47] HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel
    Hui Lyu
    Fei Shen
    Sanbao Ruan
    Congcong Tan
    Jundong Zhou
    Ann D. Thor
    Bolin Liu
    Cancer Cell International, 23
  • [48] HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel
    Lyu, Hui
    Shen, Fei
    Ruan, Sanbao
    Tan, Congcong
    Zhou, Jundong
    Thor, Ann D.
    Liu, Bolin
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [49] Discovery of novel metformin derivatives with potent antitumor activity in combination with immunotherapy for treatment of triple-negative breast cancer
    Marquez-Garban, Diana C.
    Deng, Gang
    Comin-Anduix, Begonya
    Muhunthan, Vishaka
    Ma, Gaoyuan
    Murphy, Jennifer
    Garcia, Alejandro J.
    Yanes, Cristian D.
    Burton, Lorena R.
    Hamilton, Nalo
    Shackelford, David
    Jung, Michael E.
    Pietras, Richard J.
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Therapeutic efficacy of NGY-091 against triple negative breast cancer is mediated by direct cell killing and activation of antitumor immunity
    Sharma, Sambad
    Wijerathna, Sanath
    Wu, Kerui
    Tyagi, Abhishek
    Wu, Shih-Ying
    Watabe, Kounosuke
    Kuklin, Nelly
    Escobedo, Jaime
    Sandanayaka, Vincent
    CANCER RESEARCH, 2023, 83 (05)
12345